Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
NCI
Oct 15, 2023, 17:22 |
Blog
Michelle Mitchell on The Francis Crick Institute Cut + Paste exhibition
Michelle Mitchell shared the following on LinkedIn: "It was wonderful to come together with some of…
Oct 15, 2023, 17:13 |
Blog
Ana Patricia Ortiz: Thank you NCI Disparities for highlighting and supporting our work to increase diversity in clinical research and in the scientific workforce!
Ana Patricia Ortiz, Investigator and Coordinator in the Cancer Control and Population Sciences Program, shared…
Oct 15, 2023, 16:12 |
Insight
Venky (Venkatraman Radhakrishnan): On multivariate analysis NCI high risk, MRD positive and CD 20 positive associated with inferior survival
Venky (Venkatraman Radhakrishnan), Associate Professor in Medical and Pediatric Oncology at the Cancer Institute in Chennai, India.…
Oct 13, 2023, 17:28 |
Career
ASCO proudly endorses NCI Director Monica Bertagnolli as next NIH Director and looks forward to her 10/18 Senate hearing - ASCO.
ASCO shared on Twitter/X: "ASCO proudly endorses NCI Director Monica Bertagnolli as next NIH Director…
Oct 13, 2023, 12:32 |
Blog
Silencing the voice of democracy in Nagorno-Karabakh: the unfolding forced displacement crisis
by Stella Arakelyan, MD, MPH, MSc, PhD 1,2 , Jemma Arakelyan, MD, PhDc 2,3 ,…
Oct 11, 2023, 19:23 |
Blog
Valerian Mwenda: Decentralizing cancer care can enhance equity, reduce financial toxicity and improve outcomes. Here we share Kenya's experience in the last five years.
Valerian Mwenda, Medical Epidemiologist at National Cancer Control Programme, shared on LinkedIn: "Decentralizing cancer care…
Oct 11, 2023, 19:17 |
Career
We are thrilled to announce the latest addition to our esteemed advisory board, Dr. Aditi Hazra, whose wealth of knowledge and extensive experience will play a pivotal role in advancing our mission of global breast cancer prevention. - UE LifeSciences
Oct 10, 2023, 21:35 |
Opinion
Justin Taylor: We show that E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies.
Justin Taylor, Assistant Professor at UM Sylvester Comprehensive Cancer Center and Principle Investigator at the…
Oct 9, 2023, 18:54 |
Blog
Ishwaria Subbiah: And that’s a wrap! Cheers from your planning committee for the 2023 Workshop on Assessing and Advancing Progress in the Delivery of High-Quality Cancer Care, co-hosted by ASCO and National Cancer Policy Forum!
Oct 9, 2023, 18:18 |
Blog
Vivek Subbiah: Mark your calendars if you are attending the NCI AACR EORTC 2023- The triple meeting in Boston, Oct 11-15.
Vivek Subbiah shared on LinkedIn: “Mark your calendars if you are attending the NCI AACR…
73
74
75
76
77
All:
5968
Posts:
741 - 750
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube